General Information
Revision date
2022-05-12
Product name
INCRUSE ELLIPTA
Product Synonyms
INCRUSE * ROLUFTA * VANISTO * UMECLIDINIUM BROMIDE, FORMULATED PRODUCT
CAS No.
869113-09-7
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H332, H412
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, inhalation Category 4 H332 - Harmful if inhaled.
Environmental hazards
Hazardous to the aquatic environment, Category 3 H412 - Harmful to aquatic life with long-term aquatic hazard long lasting effects.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
UMECLIDINIUM BROMIDE
Signal word
Warning
Hazard statements
H332 Harmful if inhaled. H412 Harmful to aquatic life with long lasting effects.
Prevention
P261 Avoid breathing dust. P271 Use only outdoors or in a well-ventilated area. P273 Avoid release to the environment.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P312 Call a POISON CENTRE/doctor/ if you feel unwell.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99.5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 99.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 99.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.